New partnership between NCD Alliance and Vantive to advance action on chronic kidney disease
The NCD Alliance is pleased to announce a new partnership with Vantive to advance action on chronic kidney disease.
Geneva, Switzerland – Chronic kidney disease (CKD), a major noncommunicable disease (NCD), affects over 850 million people worldwide and is a fast-growing burden, projected to become the fifth leading cause of death by 2040, CKD is characterised by progressive loss of kidney function, and closely linked with other NCDs such as diabetes, hypertension, and heart disease. This newly established collaboration between NCD Alliance and Vantive will raise awareness on the importance of improved access to therapies, technologies and services across the continuum of care, and support efforts to prevent and detect chronic kidney disease earlier. It will also promote the meaningful engagement of communities, people living with NCDs and civil society, with the aim of ensuring an inclusive and equitable approach to decision-making and implementation.
“This partnership is a unique opportunity to respond to the rising burden of chronic kidney disease as a part of the broader NCD response,” said NCD Alliance CEO Katie Dain. “Too many people living with chronic kidney disease are being left behind by health systems. Changing this is a priority for NCDA. Our aim is to ensure that everyone can access the care they need.”
“Advancing more accessible, connected and personalised care for kidney patients requires collaboration across organisations, sectors, and geographies,” said Chris Toth, CEO of Vantive. “We are thrilled to partner with NCDA. Together, we will work to improve the care experience and patient outcomes through more integrated, collaborative approaches to addressing major NCDs such as chronic kidney disease.”
The collaboration comes at a critical moment for global NCD action, following the fourth UN High-Level Meeting on NCDs in September 2025. The coming year will be essential for holding governments accountable for the commitments made, and for ensuring that people with lived experience and civil society play a central role in co-creating and implementing equitable solutions.
The global burden of NCDs remains unacceptable, inequitable, and on the rise. NCDs are the leading cause of death and disability worldwide. With approximately one in three people living with multiple chronic conditions and half the world's population lacking essential health services, millions are still not receiving the care they need. High-quality, specialised services – such as those required for advanced kidney disease – remain out of reach for many people around the world.